CombiMatrix's Q2 Revenues Jump 15 Percent on Prenatal Testing Demand as Loss Narrows | GenomeWeb

NEW YORK (GenomeWeb News) – CombiMatrix today reported that its second quarter revenues rose 15 percent, driven by 152 percent growth in revenues generated by its prenatal microarray testing services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.